title: Theoretical evidence of the existence of a diazafulvene intermediate in the reaction pathway of imidazoleglycerol phosphate dehydratase: design of a novel and potent heterocycle structure for the inhibitor on the basis of the electronic structure-activity relationship study.
abstract: The reaction mechanism of imidazoleglycerol phosphate dehydratase has not yet been clearly revealed. Structural comparison between inhibitors and the substrate IGP implicates that the reaction involves a diazafulvene intermediate. Here, we present evidence to support this hypothesis by investigating the electronic structure-enzyme inhibitory activity relationship on inhibitors with different heterocycles using 6-31G** level theory of the ab initio molecular orbital method. The calculation results showed that potent inhibitors can be distinguished from weak ones by the atomic charge density and by the energy levels of the highest occupied lone-pair orbital on the nitrogen atoms in the heterocycles. Furthermore, very good correlations (r2=0.8-0.9) were found between the charge density on the nitrogen atom and the inhibitory activity. It was also revealed that the diazafulvene is electronically similar to the potent inhibitors. Thus, these results strongly suggest the existence of the diazafulvene as an intermediate possessing tight-binding affinity to the enzyme. Based on the electronic structural similarity between the potent inhibitors and the proposed intermediate, a novel heterocycle was designed and predicted its inhibitory activity prior to the synthesis. Then, activity of synthesized inhibitors showed excellent agreement with this prediction. Hence, from the theoretical studies and experimental results, we conclude to obtain evidence of the hypothesis that the enzyme reaction proceeds via the diazafulvene intermediate.
authors.affiliation: Computer Chemistry Unit, International Research Laboratories, CIBA-GEIGY Japan, P.O. Box 1, Takarazuka, Hyogo 665, Japan. keigo.gohda@pharma.novartis.com
authors.forename: K
authors.initials: K
authors.lastname: Gohda
authors.forename: Y
authors.initials: Y
authors.lastname: Kimura
authors.forename: I
authors.initials: I
authors.lastname: Mori
authors.forename: D
authors.initials: D
authors.lastname: Ohta
authors.forename: T
authors.initials: T
authors.lastname: Kikuchi
mesh_terms: D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry*; D006836:Hydro-Lyases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D007093:Imidazoles / Q000737:chemistry* / Q000378:metabolism; D008958:Models, Molecular; D015394:Molecular Structure; D011789:Quantum Theory; D013329:Structure-Activity Relationship; D013830:Thiadiazoles / Q000737:chemistry* / Q000494:pharmacology; D014230:Triazoles / Q000737:chemistry / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D007093:Imidazoles; D013830:Thiadiazoles; D014230:Triazoles; C113487:diazafulvene; D006836:Hydro-Lyases; C021434:imidazoleglycerolphosphate dehydratase